Literature DB >> 15638757

Animal models of depressive illness: the importance of chronic drug treatment.

P J Mitchell1, P H Redfern.   

Abstract

A wide diversity of animal models has been used to examine antidepressant activity. These range from relatively simple models sensitive to acute treatment, to highly sophisticated models that reputedly model some aspect of depressive illness and which yield a positive response to prolonged, chronic, drug treatment. In recent years antidepressant drug research has focused on the search for antidepressant therapy that has a more rapid onset of action. To be relevant, therefore, animal models must measure the time course of drug action. This review examines the claims of animal models to be sensitive to chronic drug treatment and considers their relevance. First, the review addresses the criteria necessary to examine the validity of animal models of depressive illness. Second, those animal models sensitive to chronic antidepressant treatment are reviewed with respect to their validity as animal models of either depressive illness and/or antidepressant activity. In particular, the development and utility of two "ethologically-relevant" animal models, the resident-intruder and social hierarchy paradigms, are described in detail. These models of rodent social and agonistic behaviour demonstrate that acute and chronic treatment with antidepressant drugs (regardless of their acute pharmacological activity) induce diametrically opposite changes in rodent agonistic behaviour. It is argued that the common ability of chronic treatment to increase rodent aggression (which in turn results in increased hierarchical status in closed social groups) most likely reflects the increased assertiveness and associated externalization of emotions expressed during recovery from depressive illness. Finally, findings that relate observed behavioural changes to underlying neurochemical changes are briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638757     DOI: 10.2174/1381612053382250

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  17 in total

Review 1.  Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications.

Authors:  John Dunlop; Karen L Marquis; H K Lim; Louis Leung; John Kao; Cynthia Cheesman; Sharon Rosenzweig-Lipson
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays.

Authors:  Emma Perez-Costas; Paolo Guidetti; Miguel Melendez-Ferro; Joyce J Kelley; Rosalinda C Roberts
Journal:  J Neural Transm (Vienna)       Date:  2008-01-11       Impact factor: 3.575

3.  Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice.

Authors:  Abdulrahman Almatroudi; Stephen M Husbands; Christopher P Bailey; Sarah J Bailey
Journal:  J Psychopharmacol       Date:  2015-06-04       Impact factor: 4.153

4.  Acute Stress Promotes Aggressive-Like Behavior in Rats Made Allergic to Tree Pollen.

Authors:  Leonardo H Tonelli; Akina Hoshino; Morgan Katz; Teodor T Postolache
Journal:  Int J Child Health Hum Dev       Date:  2008

5.  Chronic social defeat downregulates the 5-HT1A receptor but not Freud-1 or NUDR in the rat prefrontal cortex.

Authors:  Niamh Kieran; Xiao-Ming Ou; Abiye H Iyo
Journal:  Neurosci Lett       Date:  2009-12-18       Impact factor: 3.046

Review 6.  Behavioral animal models of depression.

Authors:  Hua-Cheng Yan; Xiong Cao; Manas Das; Xin-Hong Zhu; Tian-Ming Gao
Journal:  Neurosci Bull       Date:  2010-08       Impact factor: 5.203

7.  Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress.

Authors:  R J Schloesser; M Lehmann; K Martinowich; H K Manji; M Herkenham
Journal:  Mol Psychiatry       Date:  2010-03-23       Impact factor: 15.992

Review 8.  Innovative approaches for the development of antidepressant drugs: current and future strategies.

Authors:  Lee E Schechter; Robert H Ring; Chad E Beyer; Zoë A Hughes; Xavier Khawaja; Jessica E Malberg; Sharon Rosenzweig-Lipson
Journal:  NeuroRx       Date:  2005-10

9.  Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents.

Authors:  Sharon Rosenzweig-Lipson; Annmarie Sabb; Gary Stack; Paul Mitchell; Irwin Lucki; Jessica E Malberg; Steve Grauer; Julie Brennan; John F Cryan; Stacey J Sukoff Rizzo; John Dunlop; James E Barrett; Karen L Marquis
Journal:  Psychopharmacology (Berl)       Date:  2007-02-13       Impact factor: 4.415

10.  Signatures of depression in non-stationary biometric time series.

Authors:  Milka Culic; Biljana Gjoneska; Hiie Hinrikus; Magnus Jändel; Wlodzimierz Klonowski; Hans Liljenström; Nada Pop-Jordanova; Dan Psatta; Dietrich von Rosen; Björn Wahlund
Journal:  Comput Intell Neurosci       Date:  2009-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.